Foclivia, Injektionssuspension in einer Durchstechflasche

7680661610010 CH-66161 Injektionssuspension
Foclivia, Injektionssuspension in einer Durchstechflasche
Foclivia, Injektionssuspension in einer Durchstechflasche
Foclivia, Injektionssuspension in einer Durchstechflasche
1 / 3
google

Article details

Package size
10
Selling units
10
Measure
Durchstechflasche(n)
Galenic form
Injektionssuspension
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
(N/A)
7.5 UG Substance Wirkstoff (Principe actif)
(N/A)
- Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
50.0 UG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
1.9 MG Substance HBESI
(N/A)
0.08 MG Substance HBESI

Authorization holder

Vifor (International) Inc.

9014 St. Gallen

Authorization information

Swissmedic authorization number
66161
Drug name
Foclivia, Injektionssuspension in einer Durchstechflasche
Galenic form
SUPA
ATC Code
J07BB02
Authorization status
Z
Dispensing category
B
First authorization
20/04/2018
Authorization expiration date
31/12/9999
IT Number
08.08.
Domain
Human medicine
Field of application
Pandemischer Influenza Impfstoff

Package details

Description (FR)
FOCLIVIA susp inj flac 10 x 0.5 ml
Description (DE)
FOCLIVIA Inj Susp Durchstf 10 x 0.5 ml
Market launch
20/04/2018
Narcotic (BTM)
No